<?xml version="1.0" encoding="UTF-8"?>
<p>In conclusion, HCV infection has long been recognized as the main liver disease in kidney transplantation. Despite the lack of efficacious and safe therapies for HCV in kidney transplant recipients until recently, during the study period we had satisfactory outcomes. This experience can be used for future comparisons with studies in the era after the introduction of new antiviral drugs now available.</p>
